ARS Pharmaceuticals, Inc. (SPRY) Working Capital

Annual Working Capital:

$310.86M+$81.68M(+35.64%)
December 31, 2024

Summary

  • As of today, SPRY annual working capital is $310.86 million, with the most recent change of +$81.68 million (+35.64%) on December 31, 2024.
  • During the last 3 years, SPRY annual working capital has risen by +$258.31 million (+491.62%).
  • SPRY annual working capital is now -18.42% below its all-time high of $381.06 million, reached on December 1, 2020.

Performance

SPRY Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Quarterly Working Capital:

$287.99M+$52.15M(+22.11%)
September 30, 2025

Summary

  • As of today, SPRY quarterly working capital is $287.99 million, with the most recent change of +$52.15 million (+22.11%) on September 30, 2025.
  • Over the past year, SPRY quarterly working capital has increased by +$96.14 million (+50.11%).
  • SPRY quarterly working capital is now -24.42% below its all-time high of $381.06 million, reached on December 1, 2020.

Performance

SPRY Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

SPRY Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+35.6%+50.1%
3Y3 Years+491.6%+7.9%
5Y5 Years+4301.9%-24.4%

SPRY Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+491.6%-7.4%+50.1%
5Y5-Year-18.4%+491.6%-24.4%+50.1%
All-TimeAll-Time-18.4%+4301.9%-24.4%+3992.8%

SPRY Working Capital History

DateAnnualQuarterly
Sep 2025
-
$287.99M(+22.1%)
Jun 2025
-
$235.84M(-14.6%)
Mar 2025
-
$276.24M(-11.1%)
Dec 2024
$310.86M(+35.6%)
$310.86M(+62.0%)
Sep 2024
-
$191.85M(-10.2%)
Jun 2024
-
$213.71M(-3.9%)
Mar 2024
-
$222.29M(-3.0%)
Dec 2023
$229.17M(-15.8%)
$229.17M(-1.8%)
Sep 2023
-
$233.29M(-4.8%)
Jun 2023
-
$244.98M(-4.9%)
Mar 2023
-
$257.51M
DateAnnualQuarterly
Dec 2022
$272.26M(+418.2%)
-
Sep 2022
-
$266.81M(+5.9%)
Jun 2022
-
$251.99M(+2.2%)
Mar 2022
-
$246.52M(-0.0%)
Dec 2021
$52.54M(-86.2%)
-
Dec 2021
-
$246.60M(-15.0%)
Sep 2021
-
$290.01M(-16.5%)
Jun 2021
-
$347.48M(-5.3%)
Mar 2021
-
$366.75M(-3.8%)
Dec 2020
$381.06M(+5250.8%)
$381.06M(+5250.8%)
Dec 2019
-$7.40M(-147.3%)
-$7.40M
Dec 2018
$15.63M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual working capital?
  • What is the all-time high annual working capital for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual working capital year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly working capital?
  • What is the all-time high quarterly working capital for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly working capital year-on-year change?

What is ARS Pharmaceuticals, Inc. annual working capital?

The current annual working capital of SPRY is $310.86M

What is the all-time high annual working capital for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual working capital is $381.06M

What is ARS Pharmaceuticals, Inc. annual working capital year-on-year change?

Over the past year, SPRY annual working capital has changed by +$81.68M (+35.64%)

What is ARS Pharmaceuticals, Inc. quarterly working capital?

The current quarterly working capital of SPRY is $287.99M

What is the all-time high quarterly working capital for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly working capital is $381.06M

What is ARS Pharmaceuticals, Inc. quarterly working capital year-on-year change?

Over the past year, SPRY quarterly working capital has changed by +$96.14M (+50.11%)
On this page